J.25_ASPIRE_Required_PEPFAR_Indicators_and_COP19_ASPIRE_Targets.pdf
PDF 108 KB Posted
- Solicitation number
- 72067419R00015
About this file
This notice describes a forthcoming request for proposal from the United States Agency for International Development South Africa for the Attain & Sustain 95-95-95, Prevent New Infections and Reach All Populations for Epidemic Control activity in Eswatini. The goal of the activity is to reduce HIV incidence and AIDS-related mortality by achieving and sustaining 95-95-95 targets across Hhohho and Shiselweni regions for all population groups through comprehensive HIV support and technical assistance at regional and facility levels. The activity will focus on increasing access to and utilization of quality HIV services, increasing uptake of biomedical prevention services and integrated sexual and reproductive health services, and improving Ministry of Health capacity for clinical oversight, pediatric HIV services, pre-exposure prophylaxis, and select maternal and child health programs. USAID intends to award a cost-plus-fixed-fee completion contract for an estimated five-year period with an overall estimated cost of $58-60 million.
72067419R00015 Amendment 1: New Attachment J.25 ASPIRE Required PEPFAR Indicators and COP19 ASPIRE Targets
View the file
Other files
Show all 30
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
J.25 ASPIRE Required PEPFAR Indicators and COP19 ASPIRE Targets
Indicator Code COP19 Target Indicator Description
CXCA_SCRN 8441 Percentage of HIV-positive women on ART screened for cervical cancer
CXCA_TX1
Percentage of cervical cancer screen-positive women who are HIV-positive and on ART eligible for cryotherapy, thermocoagulation or LEEP who received cryotherapy, thermocoagulation or LEEP
GEND_GBV 945
Number of people receiving post-gender-based violence (GBV) clinical care based on the minimum package
HTS_INDEX 7680
Number of individuals who were identified and tested using Index testing services and received their results
HTS_RECENT 2585
Percentage of persons aged ≥15 years newly diagnosed with HIV-1 infection who have a test for recent infection result of ‘recent infection’ during the reporting period
HTS_SELF 2947 Number of individual HIV self-test kits distributed
HTS_TST 22723
Number of individuals who received HIV Testing Services (HTS) and received their test results
HTS_TST_POS 4020
Number of individuals who received HIV Testing Services (HTS), received their test results, and tested HIV positive.
PMTCT_ART 1901
Percentage of HIV-positive pregnant women who received ART to reduce the risk of mother-to-child-transmission (MTCT) during pregnancy
PMTCT_EID 1896
Percentage of infants born to HIV-positive women who received a first virologic HIV test (sample collected) by 12 months of age
PMTCT_STAT 5724
Percentage of pregnant women with known HIV status at antenatal care (includes those who already knew their HIV status prior to ANC)
PrEP_CURR 835 Number of individuals, inclusive of those newly enrolled, that received oral antiretroviral pre-exposure prophylaxis (PrEP) to prevent HIV during the reporting period
PrEP_NEW 683 Number of individuals who have been newly enrolled on antiretroviral pre-exposure prophylaxis (PrEP) to prevent HIV infection in the reporting period
TB_ART 285
Proportion of HIV-positive new and relapsed TB cases on ART during TB treatment
TB_PREV 10810
Proportion of ART patients who completed a standard course of TB preventive therapy within the semiannual reporting period
TB_STAT 433 Percentage of new and relapse TB cases with documented HIV status
TX_CURR 78936 Number of adults and children currently receiving antiretroviral therapy (ART)
TX_NEW 4611 Number of adults and children newly enrolled on antiretroviral therapy (ART)
TX_PVLS 39586
Percentage of ART patients with a suppressed viral load (VL) result (<1000 copies/ml) documented in the medical or laboratory records/laboratory information systems (LIS) within the past 12 months
TX_TB 47576
Proportion of ART patients screened for TB in the semiannual reporting period who start TB treatment.
VMMC_CIRC 3661
Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period
1 There are no COP19 targets for CXCA_TX, however ASPIRE will be required to report results.
File details come from the government source that posted it. Updated .